麻症的药理和基于设备的干预措施:基于clinicaltrials.gov的临床试验分析
Nasser M Alorfi1, Fahad S Alshehri1,2, Saad M Wali1
1Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Medicine
|February 27, 2026
概括
临床试验越来越多地侧重于基于设备和药物干预的临床试验,以改善运动能力和减少并发症. 试验设计和结果的标准化对于推进有效的残症治疗至关重要.
科学领域:
- 神经科学与康复医学 神经科学与康复医学
- 临床试验分析
- 医疗技术评估 医疗技术评估
背景情况:
- 由脊髓损伤或神经疾病引起的,需要先进的长期护理和康复策略.
- 改善流动性,管理并发症和提高生活质量是护理管理的关键目标.
- 对临床试验进行系统分析对于了解当前的研究趋势和治疗进展至关重要.
研究的目的:
- 系统地分析在ClinicalTrials.gov上注册的临床试验,调查对的干预措施.
- 根据干预类型,类别和主要结果重点对研究进行分类.
- 确定对的药理学,基于设备和程序治疗的趋势.
主要方法:
- 在ClinicalTrials.gov.gov上注册的84项与相关的临床试验的回顾性分析.
- 根据试验类型 (干预/观察) 和干预类别 (药物学,基于设备,行为学,生物学,程序学) 分类研究.
- 对样本大小,招生和主要结果类别的描述性分析,重点是干预性试验.
主要成果:
- 在84项试验中,有61项是干预性,重点是基于设备 (n=30) 和药理学 (n=10) 的干预.
- 基于设备的疗法包括外骨,功能电刺激和机器人.
- 药理干预针对性,神经保护和心血管调节;流动性/功能是最常见的结果.
- 许多研究报告的样本大小小小,表明需要更大,更标准化的试验.
结论:
- 麻研究正在转向药理和设备支持的干预措施,以增强运动恢复和减轻二次残疾.
- 目前的试验显示了优化长期残肢管理的有希望的方向.
- 临床试验设计和结果报告的标准化对于提高治疗有效性和临床适用性至关重要.
更多相关视频
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications


